The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis

  • A. Stefferl
  • U. Brehm
  • C. Linington
Conference paper


The myelin oligodendrocyte glycoprotein (MOG) is a major target for autoantibody mediated demyelination in experimental autoimmune encephalomyelitis (EAE). In the current review we discuss the epitope specificity of this antibody response, in particular evidence suggesting that pathogenic anti-MOG antibodies are preferentially directed against conformationdependent epitopes present on the extracellular immunoglobulin domain of the protein. Surprisingly, recent data suggest that this autoimmune response is in part regulated by polymorphisms in the MOG gene itself, an observation that may have important implications for the genetic and immunological stratification of patients with multiple sclerosis.


Multiple Sclerosis Experimental Autoimmune Encephalomyelitis Experimental Allergic Encephalomyelitis Brown Norway Myelin Debris 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu J-M, et al. (1995) The N-terminal domain of the myelin oligodoendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 63: 17–27PubMedCrossRefGoogle Scholar
  2. Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H (1997) Experimental autoimmune encephalomyelitis: The antigen specificity of T-lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 76: 355–364PubMedGoogle Scholar
  3. Brehm U, Piddlesden S.J., Gardinier M.V., Linington C (1999) Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG). J Neuroimmunol 97: 9–15PubMedCrossRefGoogle Scholar
  4. Brunner C, Lassmann H, Waehneldt T.V., Matthieu J-M, Linington C (1989) Differential ultrastructurallocalization of myelin basic protein, myelin/oligodendrocyte glycoprotein, and 2’,3’-cyclic nucleotide 3’-phosphodiesterase in the CNS of adult rats. J Neurochem 52: 296–304PubMedCrossRefGoogle Scholar
  5. della Gaspera B, Pham-Dinh D, Roussel G, Nussbaum J.L., Dautigny A (1998) Membrane topology of the myelin/oligodendrocyte glycoprotein. Eur J Biochem 258: 478–484PubMedCrossRefGoogle Scholar
  6. Gardinier M.V., Amiguet P, Linington C, Matthieu J-M (1992) Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J Neurosci Res 33: 177–187PubMedCrossRefGoogle Scholar
  7. Gasser D.L., Newlin C.M., Palm J, Gonatas N.K. (1973) Genetic control of susceptibility to experimental allergic encephalomyelitis in rats. Science 181: 872–873PubMedCrossRefGoogle Scholar
  8. Genain C.P., Hauser S.L. (1997) Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. J Mol Med 75: 187–197PubMedCrossRefGoogle Scholar
  9. Genain CP, Cannella B, Hauser SL, Raine CS (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 5: 170–175PubMedCrossRefGoogle Scholar
  10. Ichikawa M, Johns T.G., Adelmann M, Bernard C.C. (1996) Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides. Int Immunol 8: 1667–1674PubMedCrossRefGoogle Scholar
  11. Ichikawa M, Johns T.G., Liu J, Bernard C.C. (1996) Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J Immunol 157: 919–926PubMedGoogle Scholar
  12. Ichikawa M, Koh C.S., Inaba Y, Seki C, Inoue A, Itoh M, Ishihara Y, Bernard C.C., Komiyama A (1999) IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice. Cell Immunol 191: 97–104PubMedCrossRefGoogle Scholar
  13. Johns T.G., Kerlero de Rosbo N, Menon K.K., Abo S, Gonzales M.F., Bernard C.C. (1995) Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 154: 5536–5541PubMedGoogle Scholar
  14. Karni A, Bakimer-Kleiner R, Abramsky O, Ben-Nun A (1999) Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Arch Neurol 56: 311–315PubMedCrossRefGoogle Scholar
  15. Kerlero de Rosbo N, Milo R, Lees M.B., Burger D, Bernard C.C.A., Ben-Nun A (1993) Reactivity to myelin antigens in multiple sclerosis. J Clin Invest 92: 2602–2608CrossRefGoogle Scholar
  16. Kerlero de Rosbo N, Hoffman M, Mendel I, Yust I, Kaye J, Bakimer R, et al. (1997) Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol 27: 3059–3069CrossRefGoogle Scholar
  17. Kroepfl J.F., Viise L.R., Charron A.J., Linington C, Gardinier M.V. (1996) Investigation of myelin/oligodendrocyte glycoprotein membrane topology. J Neurochem 67: 2219–2222PubMedCrossRefGoogle Scholar
  18. Lambracht D, Prokop C, Hedrich H.J., Fischer Lindahl K, Wonigeit K (1995) Mapping of H2-M homolog and MOG genes in the rat MHC. Immunogen 42: 418–421Google Scholar
  19. Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol 75: 566–576PubMedCrossRefGoogle Scholar
  20. Lebar R, Lubetzki C, Vincent C, Lombrail P, Poutry J-M (1986) The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membranes. Clin Exp Immunol 66: 432–443Google Scholar
  21. Lindert R, Haase C.G., Brehm U, Linington C, Wekerle H, Hohlfeld R (1999) MUltiple sclerosis: T and B cell responses to the extracellular domain of the myelin glycoprotein. Brain 122: 2089–2099PubMedCrossRefGoogle Scholar
  22. Linington C, Lassmann H (1987) Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titer to myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol 17: 61–70PubMedCrossRefGoogle Scholar
  23. Linington C, Bradl M, Lassmann H, Brunner C, Vass K (1988) Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130:443–454PubMedGoogle Scholar
  24. Linington C, Morgan B.P., Scolding N.J., Piddlesden S, Wilkins P, Compston D.A.S. (1989) The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112: 895–911PubMedCrossRefGoogle Scholar
  25. Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, et al. (1993) T cells specific for the myelin oligodendrocyte glycoprotein (MOG) mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23:1364–1372PubMedCrossRefGoogle Scholar
  26. Pham-Dinh D, Mattei M.G., Nussbaum J.L., Roussel G, Pontarotti P, Roeckel N, Mather IH, Artzt K, Lindahl K.F., Dautigny A (1993) Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc Natl Acad Sci USA 90: 7990–7994PubMedCrossRefGoogle Scholar
  27. Pham-Dinh D, Jones E.P., Pitiot G, Daubas P, Blanquet F, Ressot C, et al. (1995) Physical mapping of human and mouse MOG gene at the distal end of the MHC class Ib region. Immunogenetics 42: 386–391PubMedCrossRefGoogle Scholar
  28. Piddlesden S.J., Lassmann H, Zimprich F, Morgan B.P., Linington C (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol 143: 555–564PubMedGoogle Scholar
  29. Piddlesden S.J., Storch M.K., Hibbs M, Freeman A.M., Lassmann H, Morgan B.P. (1994) Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J Immunol 152: 5477–5484PubMedGoogle Scholar
  30. Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, Poewe W, Berger T (1999) Myelin oligodendrocyte glycoprotein specific autoantibodies in multiple sclerosis. Brain 122: 2047–2056PubMedCrossRefGoogle Scholar
  31. Schluesener H.J., Sobel R.A., Linington C, Weiner H.L. (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 139: 4016–4021PubMedGoogle Scholar
  32. Storch M.K., Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H (1998a) Multiple sclerosis: in situ evidence for antibody - and complement-mediated demyelination. Ann Neurol 43: 465–471PubMedCrossRefGoogle Scholar
  33. Storch M.K., Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M, et al. (1998b) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8: 681–694PubMedCrossRefGoogle Scholar
  34. Sun J, Link H, Olsson H, Xiao B, Andersson G, Ekre H-P, et al. (1991a) T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 146: 1490–1495PubMedGoogle Scholar
  35. Wallstrom K, Khademi M, Andersoon M, Weissert R, Linington C, Olsson T (1998) Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2 (15)+ positive multiple sclerosis. Eur J Immunol 28: 3329–3335PubMedCrossRefGoogle Scholar
  36. Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C (1994) Animal models. Ann Neurol 36: S47–S53PubMedCrossRefGoogle Scholar
  37. Weissert R, Wallstorm E, Storch M.K., Stefferl A, Lorentzen J, Lassmann H, et al. (1998) MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 102: 1265–1273PubMedCrossRefGoogle Scholar
  38. Xiao B, Linington C, Link H (1991) Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 31: 91–96PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2000

Authors and Affiliations

  • A. Stefferl
    • 1
  • U. Brehm
    • 1
  • C. Linington
    • 1
  1. 1.Department of NeuroimmunologyMax-Planck-Institute for NeurobiologyPlanegg-MartinsriedFederal Republic of Germany

Personalised recommendations